ID

14932

Descripción

International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Documentation part. Clinical Trial Number: NCT01117441.

Palabras clave

Versiones (1)
  1. 9/5/16 9/5/16 -
Subido en

9 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC-ND 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

HR-3 therapy documentation AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441

Inglés

HR-3 therapy documentation AIEOP-BFM ALL 2009 NCT01117441

1 formularios  
Patient Information
Descripción

Patient Information

Alias
UMLS CUI-1
C1955348
Stud.-Nr. (Pat.-ID)
Descripción

Patient ID

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Patient date of birth
Descripción

Patient birthday

Tipo de datos

date

Alias
UMLS CUI [1]
C0421451
Body weight
Descripción

Weight

Tipo de datos

float

Unidades de medida
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Body height
Descripción

Height

Tipo de datos

float

Unidades de medida
  • cm
Alias
UMLS CUI [1]
C0005890
cm
Body surface
Descripción

Body surface

Tipo de datos

float

Unidades de medida
  • mˆ2
Alias
UMLS CUI [1]
C0005902
mˆ2
Chemotherapy Regimen
Descripción

Chemotherapy Regimen

Alias
UMLS CUI-1
C0392920
Dexamethasone administration form
Descripción

Dexamethasone: administration form

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0011777
UMLS CUI [1,2]
C0013153
Dexamethasone dosage 20 mg/mˆ2/d
Descripción

Dexamethasone: dosage

Tipo de datos

float

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0011777
UMLS CUI [1,2]
C0178602
mg
Dexamethasone Date of administration
Descripción

Dexamethasone: date of administration

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011777
UMLS CUI [1,2]
C2584899
ARA-C administration form p.i. (3h)
Descripción

ARA-C: administration form

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0010711
UMLS CUI [1,2]
C1827465
ARA-C dosage 2000 mg/mˆ2/ED
Descripción

ARA-C: dosage

Tipo de datos

float

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0010711
UMLS CUI [1,2]
C0178602
mg
ARA-C Date of administration
Descripción

ARA-C: date of administration

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0010711
UMLS CUI [1,2]
C2584899
VP-16 administration form p.i. (1h) (with MESNA: 70 mg/ˆ2 at hour 0, 4 and 8 of CPM-infusion regimen)
Descripción

VP-16: administration form

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0733688
UMLS CUI [1,2]
C1827465
VP-16 dosage 200 mg/mˆ2/ED
Descripción

VP-16: dosage

Tipo de datos

float

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0733688
UMLS CUI [1,2]
C0178602
mg
VP-16 Date of administration
Descripción

VP-16: date of administration

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0733688
UMLS CUI [1,2]
C2584899
PEG-L-ASP administration form p.i. (2h)
Descripción

PEG-L-ASP: administration form

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C1827465
PEG-L-ASP dosage 2500 mg/mˆ2/ED (ONCASPAR: 3750 E/ED)
Descripción

PEG-L-ASP: dosage

Tipo de datos

float

Unidades de medida
  • E
Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C0178602
E
PEG-L-ASP Date of administration
Descripción

PEG-L-ASP: date of administration

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C2584899
MTX administration form i.th
Descripción

MTX: administration form

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0677897
MTX dosage (Age-dependent: 1 - < 2 y/o: 8 mg 2 - < 3y/o: 10 mg >= 3 y/o: 12 mg
Descripción

MTX: dosage

Tipo de datos

float

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
mg
MTX Date of administration
Descripción

MTX: date of administration

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C2584899
PEG-L-ASP/ Erwinase
Descripción

PEG-L-ASP/ Erwinase

Alias
UMLS CUI-1
C0071568
UMLS CUI-3
C0591457
Change from PEG-L-ASP to Erwinase in this element
Descripción

Change from PEG-L-ASP to Erwinase

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0580105
UMLS CUI [1,2]
C0071568
UMLS CUI [1,3]
C0591457
If "yes", specify: Erwinase: date of first administration
Descripción

Erwinase: date of first administration

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C2584899
UMLS CUI [1,3]
C0205435
If "yes", specify: Erwinase: date of last administration
Descripción

Erwinase: date of last administration

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C2584899
UMLS CUI [1,3]
C1517741
If "yes", specify: Numbers of Erwinase doses
Descripción

Numbers of Erwinase doses

Tipo de datos

float

Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C0237753
If "yes", specify: Reason for change to erwinase: Hypersensitivity
Descripción

Reason for drug change: Hypersensitivity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C0392747
UMLS CUI [2]
C0020517
If "yes", specify: Reason for change to erwinase: Date of allergic reaction
Descripción

Reason for drug change: date of hypersensitivity

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C0392747
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0011008
If "yes", specify: Reason for change to erwinase: Other reason
Descripción

Reason for drug change: Other reason

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C0392747
UMLS CUI [2]
C3840932
Identification and Signature
Descripción

Identification and Signature

Alias
UMLS CUI-1
C0205396
UMLS CUI-3
C1519316
Date and signature of the doctor who calculated and created chemotherapy regimen
Descripción

Chemotherapy creator: signature

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1707531
UMLS CUI [2]
C1519316
Date and signature of the person who administered chemotherapy
Descripción

Chemotherapy administration: signature

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1533734
UMLS CUI [2]
C1519316
Volver a la parte superior de la página

Similar models

HR-3 therapy documentation AIEOP-BFM ALL 2009 NCT01117441

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient ID
Item
Stud.-Nr. (Pat.-ID)
text
C2348585 (UMLS CUI [1])
Patient birthday
Item
Patient date of birth
date
C0421451 (UMLS CUI [1])
Weight
Item
Body weight
float
C0005910 (UMLS CUI [1])
Height
Item
Body height
float
C0005890 (UMLS CUI [1])
Body surface
Item
Body surface
float
C0005902 (UMLS CUI [1])
Item Group
Chemotherapy Regimen
C0392920 (UMLS CUI-1)
Item
Dexamethasone administration form
text
C0011777 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
Dexamethasone: administration form
Code List
Dexamethasone administration form
CL Item
p.o (p.o)
CL Item
i.v. (i.v.)
Dexamethasone: dosage
Item
Dexamethasone dosage 20 mg/mˆ2/d
float
C0011777 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Dexamethasone: date of administration
Item
Dexamethasone Date of administration
date
C0011777 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
ARA-C: administration form
Item
ARA-C administration form p.i. (3h)
boolean
C0010711 (UMLS CUI [1,1])
C1827465 (UMLS CUI [1,2])
ARA-C: dosage
Item
ARA-C dosage 2000 mg/mˆ2/ED
float
C0010711 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
ARA-C: date of administration
Item
ARA-C Date of administration
date
C0010711 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
VP-16: administration form
Item
VP-16 administration form p.i. (1h) (with MESNA: 70 mg/ˆ2 at hour 0, 4 and 8 of CPM-infusion regimen)
boolean
C0733688 (UMLS CUI [1,1])
C1827465 (UMLS CUI [1,2])
VP-16: dosage
Item
VP-16 dosage 200 mg/mˆ2/ED
float
C0733688 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
VP-16: date of administration
Item
VP-16 Date of administration
date
C0733688 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
PEG-L-ASP: administration form
Item
PEG-L-ASP administration form p.i. (2h)
boolean
C0071568 (UMLS CUI [1,1])
C1827465 (UMLS CUI [1,2])
PEG-L-ASP: dosage
Item
PEG-L-ASP dosage 2500 mg/mˆ2/ED (ONCASPAR: 3750 E/ED)
float
C0071568 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
PEG-L-ASP: date of administration
Item
PEG-L-ASP Date of administration
date
C0071568 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
MTX: administration form
Item
MTX administration form i.th
boolean
C0025677 (UMLS CUI [1,1])
C0677897 (UMLS CUI [1,2])
MTX: dosage
Item
MTX dosage (Age-dependent: 1 - < 2 y/o: 8 mg 2 - < 3y/o: 10 mg >= 3 y/o: 12 mg
float
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
MTX: date of administration
Item
MTX Date of administration
date
C0025677 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
Item Group
PEG-L-ASP/ Erwinase
C0071568 (UMLS CUI-1)
C0591457 (UMLS CUI-3)
Change from PEG-L-ASP to Erwinase
Item
Change from PEG-L-ASP to Erwinase in this element
boolean
C0580105 (UMLS CUI [1,1])
C0071568 (UMLS CUI [1,2])
C0591457 (UMLS CUI [1,3])
Erwinase: date of first administration
Item
If "yes", specify: Erwinase: date of first administration
date
C0591457 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
Erwinase: date of last administration
Item
If "yes", specify: Erwinase: date of last administration
date
C0591457 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,3])
Numbers of Erwinase doses
Item
If "yes", specify: Numbers of Erwinase doses
float
C0591457 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Reason for drug change: Hypersensitivity
Item
If "yes", specify: Reason for change to erwinase: Hypersensitivity
boolean
C0591457 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2])
Reason for drug change: date of hypersensitivity
Item
If "yes", specify: Reason for change to erwinase: Date of allergic reaction
date
C0591457 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0011008 (UMLS CUI [2,2])
Reason for drug change: Other reason
Item
If "yes", specify: Reason for change to erwinase: Other reason
text
C0591457 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C3840932 (UMLS CUI [2])
Item Group
Identification and Signature
C0205396 (UMLS CUI-1)
C1519316 (UMLS CUI-3)
Chemotherapy creator: signature
Item
Date and signature of the doctor who calculated and created chemotherapy regimen
text
C0392920 (UMLS CUI [1,1])
C1707531 (UMLS CUI [1,2])
C1519316 (UMLS CUI [2])
Chemotherapy administration: signature
Item
Date and signature of the person who administered chemotherapy
text
C0392920 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C1519316 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial